Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Calliditas Therapeutics’ nomination committee for the AGM 2022

Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2022.The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting in 2017, consists of: • Patrick Sobocki, appointed by Stiftelsen Industrifonden • Karl Tobieson, appointed by Linc AB • Pär Sjögemark, appointed by Handelsbanken Fonder • Elmar Schnee (chairman of the board of directors) The nomination committee shall, before the annual general meeting 2022, prepare a proposal for the election of chairman and other

Reminder: Invitation to Multiconsult ASA’s third quarter and Capital Markets Day at MUNCH

Multiconsult ASA's third quarter 2021 results will be released on Wednesday 3 November at 07:00 CET. A presentation of the results followed by Capital Markets Day will be held at the new MUNCH, Edvard Munchs Plass 1, Oslo at 08:30 CET. The complete report and presentation will be available at www.multiconsult-ir.com and www.newsweb.no.Program: 08:15 Registration08:30 - 09:00 Third quarter 2021 presentation09:15 - 11:15 Capital Markets Day11:45 - 12:15 Guided tour at MUNCH Light lunch will be served at 11:15 The presentations will be held in English by CEO Grethe

IKEA increase action to enable people to live a more sustainable life at home

According to new climate action research* published by Ingka Group, the main IKEA retailer, 7 out of 10 people are worried about climate change, and 9 out of 10 people are willing to take individual action. The biggest barriers are not getting enough support from governments and businesses, that climate action is too expensive, and not knowing what to do.IKEA is taking action to become climate positive by 2030**, reducing more greenhouse gas emissions than the IKEA value chain emits, while growing the business. In addition to a range of actions across the business to reduce emissions, as

Read original

Stockholm Exergi selects IFS Cloud as part of its transformation to a climate-positive business

IFS to empower Stockholm Exergi with an industry-leading cloud platform unifying their assets, people and work processesStockholm, Sweden, November 2, 2021 – IFS , the global cloud enterprise applications company, announces that Stockholm Exergi, Stockholm’s energy company, has selected IFS Cloud™  to support its mission-critical enterprise resource planning (ERP) processes.Stockholm Exergi  ensures that more than 800,000 Stockholmers have

Humana's new President and CEO Johanna Rastad will take office in December

As previously announced (press release 2021-09-08) Johanna Rastad has been appointed new President and CEO of Humana AB, taking office during the first quarter of 2022. The Board has now, in consultation with Johanna Rastad and outgoing President and CEO Rasmus Nerman, agreed that the change of CEO will take place on 17 December 2021.– During the autumn Johanna Rastad and Rasmus Nerman have had time for handover and I and the Board are now looking forward to continuing our work together with Johanna Rastad and the other management, Sören Mellstig, Chairman of the Board of Humana, says. –

The Nominating Committee’s recommendations for changes in the Board of Directors of Axfood

Ahead of the Annual General Meeting on 23 March 2022, the Nominating Committee of Axfood proposes the re-election of directors Mia Brunell Livfors, Fabian Bengtsson, Caroline Berg, Christian Luiga, Christer Åberg and Peter Ruzicka, and that Sara Öhrvall be elected as a new director.The board member Stina Andersson has declined re-election. Sara Öhrvall (b. 1971) holds an MSc in International Business from Umeå University and currently works as the Chief Operating Officer at Axel Johnson. She has several years of experience in leading positions with a focus on innovation, product and

Graphic Packaging Holding Company Announces Completion of AR Packaging Acquisition; Significantly Strengthening Global Market Position in Fiber-Based Packaging Solutions

Graphic Packaging Holding Company (NYSE: GPK), (“Graphic Packaging”), a leading vertically-integrated provider of sustainable fiber-based consumer packaging solutions, today announced the successful close of its acquisition of AR Packaging Group AB, Europe’s second largest producer of fiber-based consumer packaging. The acquisition accelerates Graphic Packaging’s growing position serving consumer packaged goods companies around the world with sustainable fiber-based packaging alternatives.     Graphic Packaging announced its intent to acquire AR Packaging Group AB on May 14, 2021.

Shareholders’ Nomination Board’s proposals regarding the composition and remuneration of the Board of Directors of Metso Outotec

Metso Outotec Corporation’s stock exchange release on November 2, 2021, at 10:00 a.m. EETMetso Outotec’s Shareholders’ Nomination Board will propose to the Annual General Meeting, planned to be held on April 21, 2022, that the Board of Directors would have nine members and that Klaus Cawén, Christer Gardell, Antti Mäkinen, Ian W. Pearce, Emanuela Speranza, Kari Stadigh, and Arja Talma would be re-elected as Board members.The Nomination Board will propose that Brian Beamish and Terhi Koipijärvi would be elected as new Board members. Their brief presentations are attached to this release.

Brinter launches multipurpose “Brinter Core” to make high-quality 3D printing more affordable and accessible

The new entry-level 3D printer is 50% smaller and lower in cost, with the aim to make bioprinting more accessible to researchers and manufacturers for uses that range from personalized drugs to human spare partsTurku-based bioprinting startup Brinter  has today announced the launch of its new entry-level model, Brinter Core. The multi-material 3D bioprinting solution is designed to be more portable and is half the cost of its predecessor, allowing more pharmaceutical companies, hospitals, universities, and research centers to access the technology under tight

The long-term plan remains in challenging times

INTERIM REPORT JANUARY-SEPTEMBER 2021:Significant Significant events after the quarterevents in Q3 · The · The Extraordinary General Meeting on 18 October resolvedChinese and US to approve an incentive program for CEO Claus Egstrand throughpatent offices an employee option plan, a directed issue of warrants and agave advance transfer of warrants.notice of  their · On 2 November 2021, the Board of Directors decided onintention to financial targets for the company. Net sales should in 2026grant patents amount to at least 600

BioStock: Pila Pharma rounds off first quarter as a publicly traded company

So far, 2021 has been a transformative year for Pila Pharma, and the third quarter was no exception. The company can look back at a period characterised by a publicly traded share, a scientific principle being awarded the Nobel Prize, and preparations for phase II. Shifting its focus on what lies ahead, additional milestones are coming up for Pila Pharma.Read the full article at biostock.se:https://www.biostock.se/en/2021/11/pila-pharma-rounds-off-first-quarter-as-a-publicly-traded-company/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Invitation to RevolutionRace’s presentation of the interim report for the first quarter 2021/22

RVRC Holding AB (publ) will publish its iterim report for the first quarter 2021/22 on November 9, 2021 at 07.30 CET. The report will be presented in a webcast and teleconference at 10.00 the same day.Pernilla Nyrensten, CEO and Jesper Alm, CFO will present the report and answer questions. The presentation will be held in English. Follow the presentation live on: https://financialhearings.com/event/41505 To listen to the conference by phone, please dial: SE: +46850558350 UK: +443333009272 US: +16467224904 For more information, please contact: Jesper AlmCFOE-mail:

Enzymatica Board decides on financial targets

The Board of Directors of Enzymatica AB today decided on financial targets for the company. At year-end 2026, net sales should amount to at least 600 million SEK, with an EBIT margin of at least 28 %. The coronapandemic has severely impacted the company’s sales in 2021, but the Board assesses the company stands well prepared for the future.The coronapandemic and the following restrictions have led to a very low incidence of common cold viruses in 2020-2021. This severely affected Enzymatica’s sales, particularly in 2021, but there are now many signs of a recovery in the cold/flu markets

Notice of end of stabilization and partial exercise of overallotment option in Truecaller AB (publ)

Goldman Sachs Bank Europe SE ("Goldman Sachs") has, in its capacity as Joint Global Coordinator and Stabilization Manager, decided to end the stabilization period in Truecaller AB's (publ) ("Truecaller" or the "Company") class B shares traded on Nasdaq Stockholm and partially exercise the overallotment option. Goldman Sachs exercises the overallotment option in respect of 1,694,415 class B shares in Truecaller. No further stabilization measures will be effected.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, FULLY OR PARTLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA,

BioStock Studio: Ultimovacs reaches key milestones with UV1

Norwegian Ultimovacs has made some big announcements recently, including discussions for a fifth phase II clinical trial with universal cancer vaccine UV1, a private placement of 270 MNOK to fund the trial and other projects, plus the FDA’s decision to grant dual Fast Track designation for UV1 in advanced melanoma. To discuss this and more, Ultimovacs’ CEO Carlos de Sousa linked up to the BioStock Studio remotely from Oslo for a Q&A.Watch the interview with Carlos de Sousa at biostock.se : https://www.biostock.se/en/2021/11/biostock-studio-ultimovacs-reaches-

Wärtsilä and Simon Møkster Shipping to study feasibility of ammonia and LNG dual-fuel operations

Wärtsilä Corporation, Press release, 2 November 2021 at 9.30 AM EETThe technology group Wärtsilä and Norway based Simon Møkster Shipping have signed a collaboration agreement to carry out a feasibility study on utilising ammonia as the main fuel in dual-fuel engines where LNG is the alternative fuel. The aim is to demonstrate the feasibility of converting vessels for dual ammonia – LNG operation, and that it can be carried out safely and efficiently. The agreement was signed in October 2021. “We are excited to join Wärtsilä in this project. We see this as a step towards meeting our

EQT Infrastructure V holds final close – reaches hard cap with continued strong investor support

· The EQT Infrastructure V fund holds final close at EUR 15.7 billion in fee-generating assets under management, fortifying EQT’s position as one of the leading infrastructure investors globally  · Strong demand from a well-diversified, global group of existing and new investors, with a 99 percent re-up rate from the predecessor fund based on committed capital and 68 percent based on the number of investors  · Continued strong investor support for EQT Infrastructure’s purpose-driven and thematic investment strategyEQT is pleased to announce that the EQT Infrastructure V fund (the “

Epiroc acquires remaining share of Mobilaris MCE

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has acquired the remaining share of Mobilaris MCE AB, a Sweden-based company that provides advanced situational awareness solutions that optimize operations in mining and civil engineering.Mobilaris Mining and Civil Engineering (MCE), based in Luleå, Sweden, is a leading supplier of solutions that use data from personnel and machines to present real-time positioning and detailed status information in a sophisticated 3D user interface. The solution creates significant

CapMan Real Estate appoints Thomas Laakso as Investment Director to support the international growth of its hotel fund

CapMan Real Estate press release2 November 2021 at 09:30 EET CapMan Real Estate appoints Thomas Laakso as Investment Director to support the international growth of its hotel fund The appointment strengthens the fund’s international fundraising and portfolio expansion capabilities, supported by Mr. Laakso’s 20+ years of versatile international experience from leading hotel operations, hotel development, as well as hotel consulting and asset management across Europe, the Middle East, Africa and the USA. Mr. Laakso worked at Marriott International, a global portfolio of

Nordnet: Monthly statistics October

In October, 5,468,800 trades were made in listed financial instruments among Nordnet’s customers, which corresponds to 260,300 trades per day. New customers in October was 19,500, and the number of new customers in 2021 is 335,200. The total number of customers at the end of October was 1,556,700. Net savings for October was SEK 6.0 billion and the total net savings during 2021 is SEK 70.8 billion. The savings capital was SEK 762 billion and lending amounted to SEK 24.9 billion at the end of October. [][][][][][] October September Change  October Change

Northbaze Group has launched a partnership with Intraco Trading

Gothenburg, November 2nd, 2021 - Northbaze Distribution AB, is partnering up with Intraco Trading to serve as a value-added distributor in the Gifts & Premiums market within the New Wave Group (publ).Northbaze Distributution AB, part of Northbaze Group has successfully launched a partnership in the pursuit to extend its business to the Gifts channel. Initially, Northbaze will supply its branded products from JAYS and KRUSELL. With time, this will also develop into Northbaze being a producer of branded as well as non-branded products. Intraco Trading is a high-end supplier for

Greenfood signs commitment to Science Based Targets

Greenfood is taking the next big step in its ongoing sustainability work by joining the Science Based Targets initiative. SBTi is a global standard that supports companies in setting climate targets in line with what’s required to meet the Paris Agreement. In the UN’s climate panel’s new report, now approved by 195 governments, including Sweden, Finland, Germany and France, international researchers agree that we can stop at 1.5 degrees of global warming if the proper measures are taken quickly. The 1.5-degree target is crucial for our planet and our vulnerable ecosystems, and achieving

Castellum signs 20-year agreement with the Örebro County Region for approximately 8,246 sqm of office space in central Örebro

In February 2021, a letter of intent was signed between Castellum and Örebro County Region regarding the possibility of renting office space on Klostergatan 23. The agreement that has now been signed relates to 8,246 sqm of office space spread over three floors. The Örebro County Region can consequently gather the majority of its administration within one and the same premises.The Örebro County Region has for a long time had the aim of locating all its operations within a certain geographical cluster in central Örebro. The fact that the administrative activities will now be co-located at

Leading US-Swedish entrepreneur Rutger Arnhult invests in Intrance Medical Inc’s advanced stage Parkinson’s disease treatment system

Stockholm, Sweden, November 2, 2021: Leading US-Scandinavian real estate entrepreneur Rutger Arnhult has, via his private company M2 Asset Management AB, agreed to invest in New York based Intrance Medical Systems Inc. Intrance is a private biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, Mexico, South America, Japan, and Taiwan. The Company is currently raising a series A round of USD 15 million to initiate pivotal clinical trials for anticipated FDA approval and

There are no items matching the current filter
There are no more items matching the current filter
Back to top